
( Brand: Ellipsys ), ( Manufacturer Part Number: AMI-1001 ), ( Country Of Origin: United States )
The Ellipsys AMI-1001 AND-AVF Vascular Access System is a state-of-the-art solution designed for use in the repair of Arteriovenous Fistulas (AVF) and Arteriovenous Grafts (AVG) in hemodialysis patients. This system is engineered to deliver precise and controlled access into the blood vessels for minimally invasive interventions.
The Ellipsys AMI-1001 system features an innovative AndrosTM needle design. The needle's unique shape and bevel angle ensure a smooth and efficient penetration into the AVF or AVG, reducing the risk of complications such as bleeding or arterial damage. The needle is also equipped with a built-in safety mechanism that prevents accidental needle sticks, ensuring the safety of both the healthcare professional and the patient.
Once the needle has been successfully inserted, the system includes a variety of accessories to facilitate the interventional procedure. The Ellipsys AMI-1001 comes with a selection of sheaths and dilators to allow for the introduction of interventional devices, such as guidewires, catheters, and angioplasty balloons. These accessories are designed to minimize vessel trauma and provide excellent support during the procedure.
The Ellipsys AMI-1001 AND-AVF Vascular Access System is also notable for its ease of use and compatibility with various interventional devices. The system can be used with a range of guiding sheaths and catheters, allowing for flexible and efficient access to the target vessels. Additionally, the system is compatible with various imaging modalities, including ultrasound and X-ray fluoroscopy, enabling the healthcare professional to visualize the intervention in real-time and ensure accurate and safe placement of the access devices.
In summary, the Ellipsys AMI-1001 AND-AVF Vascular Access System is a versatile and advanced solution for the repair of AVF and AVG in hemodialysis patients. With its innovative needle design, wide range of accessories, and compatibility with various interventional devices and imaging modalities, the Ellipsys AMI-1001 system offers healthcare professionals the precision, control, and safety they need to perform minimally invasive interventions with confidence.
The Ellipsys AMI-1001 and OAVF (On-Avenue Access Flow) vascular access system is a minimally invasive solution for patients undergoing percutaneous coronary interventions (PCIs). This system allows for access to the coronary arteries through a small incision in the wrist instead of the traditional groin approach. Here are some pros and cons of using this system:
Pros:1. Minimally Invasive: The wrist approach with the Ellipsys AMI-1001 and OAVF system reduces the need for large groin incisions, leading to less pain, shorter hospital stays, and quicker recovery times for patients.
2. Lower Risk of Complications: Compared to the traditional femoral approach, the wrist approach carries a lower risk of complications such as bleeding, infection, and nerve damage.
3. Flexibility for Procedures: The Ellipsys AMI-1001 and OAVF system allows for greater flexibility in performing PCIs, as the smaller incision site can be easily accessed from various angles.
4. Reduced Need for Blood Transfusions: Due to the reduced risk of bleeding, patients who undergo PCI with the Ellipsys AMI-1001 and OAVF system may require fewer blood transfusions.
Cons:1. Limited Experience: The Ellipsys AMI-1001 and OAVF system is a relatively new technology, and some healthcare providers may not have extensive experience using it.
2. Higher Cost: The cost of the Ellipsys AMI-1001 and OAVF system is generally higher than the traditional femoral approach.
3. Limited Patient Population: The Ellipsys AMI-1001 and OAVF system is not suitable for all patients undergoing PCI, and it may not be the best option for those with complex coronary artery disease or other health conditions.
Conclusion:The Ellipsys AMI-1001 and OAVF system offers several advantages over the traditional femoral approach for PCI, including minimally invasive access, lower risk of complications, greater flexibility, and reduced need for blood transfusions. However, the system also comes with some limitations, such as limited experience, higher cost, and a limited patient population. Healthcare providers should carefully consider the benefits and drawbacks of the Ellipsys AMI-1001 and OAVF system and weigh them against the specific needs and preferences of their patients.
Recommendation:Based on the available evidence, the Ellipsys AMI-1001 and OAVF system can be a valuable addition to the toolkit of healthcare providers performing PCI. The system's minimally invasive approach, lower risk of complications, and flexibility make it an attractive option for many patients. However, it is essential to ensure that healthcare providers have adequate experience and training in using the system and that it is cost-effective for their institution. Ultimately, the decision to use the Ellipsys AMI-1001 and OAVF system should be based on a careful consideration of the patient's individual needs and circumstances.
No further tested. If it is not showed in our pictures and/or mentioned above, then included. Condition: Removed from working environment. Items are being sold for parts or repair only.
Warranty Period:No warranty. This is used item. This listing is for: 1 x used Ellipsys Andoavf Vascular Access System model AMI-1001. Items was tested with power on only.